<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27023634</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.</ArticleTitle><Pagination><StartPage>e0152236</StartPage><MedlinePgn>e0152236</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0152236</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0152236</ELocationID><Abstract><AbstractText>Hepatitis C virus (HCV) infection-induced oxidative stress is a major risk factor for the development of HCV-associated liver disease. Sulforaphane (SFN) is an antioxidant phytocompound that acts against cellular oxidative stress and tumorigenesis. However, there is little known about its anti-viral activity. In this study, we demonstrated that SFN significantly suppressed HCV protein and RNA levels in HCV replicon cells and infectious system, with an IC50 value of 5.7 &#xb1; 0.2 &#x3bc;M. Moreover, combination of SFN with anti-viral drugs displayed synergistic effects in the suppression of HCV replication. In addition, we found nuclear factor erythroid 2-related factor 2 (Nrf2)/HO-1 induction in response to SFN and determined the signaling pathways involved in this process, including inhibition of NS3 protease activity and induction of IFN response. In contrast, the anti-viral activities were attenuated by knockdown of HO-1 with specific inhibitor (SnPP) and shRNA, suggesting that anti-HCV activity of SFN is dependent on HO-1 expression. Otherwise, SFN stimulated the phosphorylation of phosphoinositide 3-kinase (PI3K) leading Nrf2-mediated HO-1 expression against HCV replication. Overall, our results indicated that HO-1 is essential in SFN-mediated anti-HCV activity and provide new insights in the molecular mechanism of SFN in HCV replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jung-Sheng</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Integrated Medicine, China Medical University, Taichung, 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-Chun</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chin-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Kuang</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Yao-Chin</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, HsinChu, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-Ching</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017879">Isothiocyanates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C084422">NS3 protein, hepatitis C virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013454">Sulfoxides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.18</RegistryNumber><NameOfSubstance UI="D051547">Heme Oxygenase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>GA49J4310U</RegistryNumber><NameOfSubstance UI="C016766">sulforaphane</NameOfSubstance></Chemical><Chemical><RegistryNumber>O9MIA842K9</RegistryNumber><NameOfSubstance UI="D001664">Biliverdine</NameOfSubstance></Chemical><Chemical><RegistryNumber>RFM9X3LJ49</RegistryNumber><NameOfSubstance UI="D001663">Bilirubin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001663" MajorTopicYN="N">Bilirubin</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001664" MajorTopicYN="N">Biliverdine</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051547" MajorTopicYN="N">Heme Oxygenase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017879" MajorTopicYN="N">Isothiocyanates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012093" MajorTopicYN="N">Replicon</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013454" MajorTopicYN="N">Sulfoxides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015533" MajorTopicYN="N">Transcriptional Activation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27023634</ArticleId><ArticleId IdType="pmc">PMC4811417</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0152236</ArticleId><ArticleId IdType="pii">PONE-D-15-55833</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jahan S, Ashfaq UA, Qasim M, Khaliq S, Saleem MJ, Afzal N. Hepatitis C virus to hepatocellular carcinoma. Infectious agents and cancer. 2012;7(1):2 10.1186/1750-9378-7-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-9378-7-2</ArticleId><ArticleId IdType="pmc">PMC3293064</ArticleId><ArticleId IdType="pubmed">22289144</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: past, present, and future. Journal of gastroenterology. 2006;41(1):17&#x2013;27. 10.1007/s00535-005-1740-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-005-1740-7</ArticleId><ArticleId IdType="pubmed">16501853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins C, Gibson W, Klibanov OM. Harvoni (ledipasvir and sofosbuvir) for hepatitis C. The Nurse practitioner. 2015;40(11):22&#x2013;6. 10.1097/01.NPR.0000472253.59198.1c .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NPR.0000472253.59198.1c</ArticleId><ArticleId IdType="pubmed">26474199</ArticleId></ArticleIdList></Reference><Reference><Citation>Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer letters. 2006;233(2):208&#x2013;18. 10.1016/j.canlet.2005.02.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2005.02.033</ArticleId><ArticleId IdType="pmc">PMC2276573</ArticleId><ArticleId IdType="pubmed">16520150</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P, Kim B, Kim SH, Srivastava SK. Molecular targets of isothiocyanates in cancer: recent advances. Molecular nutrition &amp; food research. 2014;58(8):1685&#x2013;707. 10.1002/mnfr.201300684</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201300684</ArticleId><ArticleId IdType="pmc">PMC4122603</ArticleId><ArticleId IdType="pubmed">24510468</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CC, Chuang HY, Lin CY, Chen YJ, Tsai WH, Fang CY, et al. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane. Molecular carcinogenesis. 2013;52(12):946&#x2013;58. 10.1002/mc.21926 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.21926</ArticleId><ArticleId IdType="pubmed">22641235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesic MJ, Simmons SO, Bauer R, Jaspers I. Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free radical biology &amp; medicine. 2011;51(2):444&#x2013;53. 10.1016/j.freeradbiomed.2011.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.04.027</ArticleId><ArticleId IdType="pmc">PMC3135631</ArticleId><ArticleId IdType="pubmed">21549835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Liu J, Chen SY. Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response. British journal of pharmacology. 2013;169(2):437&#x2013;48. 10.1111/bph.12133</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12133</ArticleId><ArticleId IdType="pmc">PMC3651668</ArticleId><ArticleId IdType="pubmed">23425096</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. Journal of biochemistry and molecular biology. 2004;37(2):139&#x2013;43. .</Citation><ArticleIdList><ArticleId IdType="pubmed">15469687</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, He M, Liu R, Brecha NC, Yu AC, Pu M. Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway. PloS one. 2014;9(12):e114186 10.1371/journal.pone.0114186</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114186</ArticleId><ArticleId IdType="pmc">PMC4254947</ArticleId><ArticleId IdType="pubmed">25470382</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarozzi A, Morroni F, Merlicco A, Hrelia S, Angeloni C, Cantelli-Forti G, et al. Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. Journal of neurochemistry. 2009;111(5):1161&#x2013;71. 10.1111/j.1471-4159.2009.06394.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06394.x</ArticleId><ArticleId IdType="pubmed">19780897</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshi ML, Su YC, Hong JR. RNA Viruses: ROS-Mediated Cell Death. International journal of cell biology. 2014;2014:467452 10.1155/2014/467452</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/467452</ArticleId><ArticleId IdType="pmc">PMC4034720</ArticleId><ArticleId IdType="pubmed">24899897</ArticleId></ArticleIdList></Reference><Reference><Citation>Arciello M, Gori M, Balsano C. Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress. Oxidative medicine and cellular longevity. 2013;2013:971024 10.1155/2013/971024</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/971024</ArticleId><ArticleId IdType="pmc">PMC3859171</ArticleId><ArticleId IdType="pubmed">24371505</ArticleId></ArticleIdList></Reference><Reference><Citation>Davinelli S, Scapagnini G, Denaro F, Calabrese V, Benedetti F, Krishnan S, et al. Altered expression pattern of Nrf2/HO-1 axis during accelerated-senescence in HIV-1 transgenic rat. Biogerontology. 2014;15(5):449&#x2013;61. 10.1007/s10522-014-9511-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-014-9511-6</ArticleId><ArticleId IdType="pubmed">25027760</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, et al. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochemical and biophysical research communications. 2010;398(4):771&#x2013;7. 10.1016/j.bbrc.2010.07.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.07.021</ArticleId><ArticleId IdType="pubmed">20633528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, Bandyopadhyay S, et al. Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology. 2010;52(6):1897&#x2013;905. Epub 2010/11/26. 10.1002/hep.23921</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23921</ArticleId><ArticleId IdType="pmc">PMC3058505</ArticleId><ArticleId IdType="pubmed">21105106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann E, El-Tantawy WH, Ocker M, Bartenschlager R, Lohmann V, Hashemolhosseini S, et al. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology. 2010;51(2):398&#x2013;404. Epub 2010/01/02. 10.1002/hep.23339 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23339</ArticleId><ArticleId IdType="pubmed">20044809</ArticleId></ArticleIdList></Reference><Reference><Citation>Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science. 2000;290(5498):1972&#x2013;4. Epub 2000/12/09. 9039 [pii]. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11110665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Tseng CK, Wu SF, Chang FR, Chiu CC, Wu YC. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. Journal of viral hepatitis. 2011;18(7):e315&#x2013;24. 10.1111/j.1365-2893.2010.01424.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.2010.01424.x</ArticleId><ArticleId IdType="pmc">PMC7185454</ArticleId><ArticleId IdType="pubmed">21692943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in enzyme regulation. 1984;22:27&#x2013;55. .</Citation><ArticleIdList><ArticleId IdType="pubmed">6382953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Tseng CK, Chen KJ, Huang KJ, Lin CK, Lin YT. A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase. Analytical biochemistry. 2010;403(1&#x2013;2):52&#x2013;62. 10.1016/j.ab.2010.04.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2010.04.004</ArticleId><ArticleId IdType="pubmed">20382106</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Jiang H, Qu L, Yao W, Cai H, Chen L, et al. Hepatocyte nuclear factor 4alpha and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virus. Journal of virology. 2014;88(1):612&#x2013;27. 10.1128/JVI.02068-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02068-13</ArticleId><ArticleId IdType="pmc">PMC3911757</ArticleId><ArticleId IdType="pubmed">24173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin LT, Chung CY, Hsu WC, Chang SP, Hung TC, Shields J, et al. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J Hepatol. 2015;62(3):541&#x2013;8. 10.1016/j.jhep.2014.10.040 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2014.10.040</ArticleId><ArticleId IdType="pubmed">25450204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WC, Wang SY, Chiu CC, Tseng CK, Lin CK, Wang HC, et al. Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction. Antimicrobial agents and chemotherapy. 2013;57(3):1180&#x2013;91. 10.1128/AAC.02053-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02053-12</ArticleId><ArticleId IdType="pmc">PMC3591928</ArticleId><ArticleId IdType="pubmed">23254429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Tseng CK, Young KC, Sun HY, Wang SW, Chen WC, et al. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. British journal of pharmacology. 2014;171(1):237&#x2013;52. 10.1111/bph.12440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12440</ArticleId><ArticleId IdType="pmc">PMC3874710</ArticleId><ArticleId IdType="pubmed">24117426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther. 2001;298(3):865&#x2013;72. Epub 2001/08/16. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11504778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanzaki H, Shinohara F, Itohiya-Kasuya K, Ishikawa M, Nakamura Y. Nrf2 activation attenuates both orthodontic tooth movement and relapse. Journal of dental research. 2015;94(6):787&#x2013;94. 10.1177/0022034515577814 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034515577814</ArticleId><ArticleId IdType="pubmed">25795629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravets A, Hu Z, Miralem T, Torno MD, Maines MD. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. The Journal of biological chemistry. 2004;279(19):19916&#x2013;23. 10.1074/jbc.M314251200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M314251200</ArticleId><ArticleId IdType="pubmed">14988408</ArticleId></ArticleIdList></Reference><Reference><Citation>Han O. Molecular mechanism of intestinal iron absorption. Metallomics: integrated biometal science. 2011;3(2):103&#x2013;9. 10.1039/c0mt00043d .</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c0mt00043d</ArticleId><ArticleId IdType="pubmed">21210059</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredenburgh LE, Merz AA, Cheng S. Haeme oxygenase signalling pathway: implications for cardiovascular disease. European heart journal. 2015;36(24):1512&#x2013;8. 10.1093/eurheartj/ehv114</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv114</ArticleId><ArticleId IdType="pmc">PMC4475572</ArticleId><ArticleId IdType="pubmed">25827602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Jeong HY, Kim YB, Lee YJ, Won SY, Shim JH, et al. Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2012;50(2):116&#x2013;23. 10.1016/j.fct.2011.10.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2011.10.035</ArticleId><ArticleId IdType="pubmed">22019695</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C, Tao R, Yu SZ, Jin H. Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. Molecular medicine reports. 2012;5(3):847&#x2013;51. 10.3892/mmr.2011.731 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2011.731</ArticleId><ArticleId IdType="pubmed">22200816</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement S, Pascarella S, Negro F. Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress. Viruses. 2009;1(2):126&#x2013;43. 10.3390/v1020126</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v1020126</ArticleId><ArticleId IdType="pmc">PMC3185489</ArticleId><ArticleId IdType="pubmed">21994542</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Shoji I, Ogawa W, Kaneda S, Soga T, Jiang DP, et al. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. Journal of virology. 2011;85(17):8556&#x2013;68. 10.1128/JVI.00146-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00146-11</ArticleId><ArticleId IdType="pmc">PMC3165828</ArticleId><ArticleId IdType="pubmed">21697492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov AV, Smirnova OA, Petrushanko IY, Ivanova ON, Karpenko IL, Alekseeva E, et al. HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells. Viruses. 2015;7(6):2745&#x2013;70. 10.3390/v7062745</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7062745</ArticleId><ArticleId IdType="pmc">PMC4488712</ArticleId><ArticleId IdType="pubmed">26035647</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthil Kumar KJ, Liao JW, Xiao JH, Gokila Vani M, Wang SY. Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic HepG2 cells through the up-regulation of HO-1/Nrf-2 antioxidant genes. Toxicology in vitro: an international journal published in association with BIBRA. 2012;26(5):700&#x2013;8. 10.1016/j.tiv.2012.03.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2012.03.012</ArticleId><ArticleId IdType="pubmed">22484158</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcaraz MJ, Vicente AM, Araico A, Dominguez JN, Terencio MC, Ferrandiz ML. Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells. British journal of pharmacology. 2004;142(7):1191&#x2013;9. 10.1038/sj.bjp.0705821</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0705821</ArticleId><ArticleId IdType="pmc">PMC1575177</ArticleId><ArticleId IdType="pubmed">15249426</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla MY, Britigan BE, Wen F, Icardi M, McCormick ML, LaBrecque DR, et al. Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein. J Infect Dis. 2004;190(6):1109&#x2013;18. Epub 2004/08/21. 10.1086/423488 JID32407[pii]. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/423488</ArticleId><ArticleId IdType="pubmed">15319861</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla MY, Mathahs MM, Ahmad IM. Reduced heme oxygenase-1 expression in steatotic livers infected with hepatitis C virus. Eur J Intern Med. 2012;23(7):649&#x2013;55. 10.1016/j.ejim.2012.05.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2012.05.001</ArticleId><ArticleId IdType="pubmed">22939811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaziani T, Shan Y, Lambrecht RW, Donohue SE, Pietschmann T, Bartenschlager R, et al. HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. J Hepatol. 2006;45(1):5&#x2013;12. 10.1016/j.jhep.2005.12.020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2005.12.020</ArticleId><ArticleId IdType="pubmed">16530877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285(5424):110&#x2013;3. .</Citation><ArticleIdList><ArticleId IdType="pubmed">10390360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, et al. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology. 2008;48(5):1430&#x2013;9. 10.1002/hep.22491</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22491</ArticleId><ArticleId IdType="pmc">PMC2587102</ArticleId><ArticleId IdType="pubmed">18972446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, et al. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World journal of hepatology. 2013;5(10):528&#x2013;40. 10.4254/wjh.v5.i10.528</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v5.i10.528</ArticleId><ArticleId IdType="pmc">PMC3812455</ArticleId><ArticleId IdType="pubmed">24179612</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang M, Xue J, Sharma V, Habtezion A. Protective role of hemeoxygenase-1 in gastrointestinal diseases. Cell Mol Life Sci. 2015;72(6):1161&#x2013;73. 10.1007/s00018-014-1790-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1790-1</ArticleId><ArticleId IdType="pmc">PMC4342274</ArticleId><ArticleId IdType="pubmed">25428780</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W, Xu J, Ge Y, Cao H, Ge X, Luo J, et al. Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression. Journal of radiation research. 2014;55(6):1056&#x2013;65. 10.1093/jrr/rru047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrr/rru047</ArticleId><ArticleId IdType="pmc">PMC4229913</ArticleId><ArticleId IdType="pubmed">24968709</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh CT, Yen GC. Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis. 2005;26(12):2138&#x2013;48. 10.1093/carcin/bgi185 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgi185</ArticleId><ArticleId IdType="pubmed">16033772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem Pharmacol. 2008;76(8):967&#x2013;73. 10.1016/j.bcp.2008.07.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2008.07.036</ArticleId><ArticleId IdType="pmc">PMC2577694</ArticleId><ArticleId IdType="pubmed">18755157</ArticleId></ArticleIdList></Reference><Reference><Citation>Prawan A, Keum YS, Khor TO, Yu S, Nair S, Li W, et al. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Pharm Res. 2008;25(4):836&#x2013;44. 10.1007/s11095-007-9370-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-007-9370-9</ArticleId><ArticleId IdType="pubmed">17657593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim do Y, Ahn SH, Han KH. Emerging therapies for hepatitis C. Gut Liver. 2014;8(5):471&#x2013;9. 10.5009/gnl14083</Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl14083</ArticleId><ArticleId IdType="pmc">PMC4164256</ArticleId><ArticleId IdType="pubmed">25228970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yupeng He WD, Seng-Lai Tan. Emerging host cell targets for hepatitis C therapy. Drug Discovery Today. 2007;12(5&#x2013;6):209&#x2013;17. Epub 5 February 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17331885</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100(1&#x2013;2):72&#x2013;9. Epub 2005/07/13. S0378-8741(05)00325-9 [pii] 10.1016/j.jep.2005.05.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2005.05.011</ArticleId><ArticleId IdType="pubmed">16009521</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenlee H. Natural products for cancer prevention. Seminars in oncology nursing. 2012;28(1):29&#x2013;44. 10.1016/j.soncn.2011.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.soncn.2011.11.004</ArticleId><ArticleId IdType="pmc">PMC3749070</ArticleId><ArticleId IdType="pubmed">22281308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MH, Lee MY, Chuang JJ, Li YZ, Ning ST, Chen JC, et al. Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. International journal of molecular medicine. 2012;30(5):1021&#x2013;8. 10.3892/ijmm.2012.1096</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2012.1096</ArticleId><ArticleId IdType="pmc">PMC3573749</ArticleId><ArticleId IdType="pubmed">22922731</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyak SJ, Oberlies NH, Pecheur EI, Dahari H, Ferenci P, Pawlotsky JM. Silymarin for HCV infection. Antiviral therapy. 2013;18(2):141&#x2013;7. 10.3851/IMP2402</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP2402</ArticleId><ArticleId IdType="pmc">PMC4076489</ArticleId><ArticleId IdType="pubmed">23011959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciesek S, von Hahn T, Colpitts CC, Schang LM, Friesland M, Steinmann J, et al. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology. 2011;54(6):1947&#x2013;55. 10.1002/hep.24610 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.24610</ArticleId><ArticleId IdType="pubmed">21837753</ArticleId></ArticleIdList></Reference><Reference><Citation>Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, et al. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology. 2012;55(3):720&#x2013;9. 10.1002/hep.24803 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.24803</ArticleId><ArticleId IdType="pubmed">22105803</ArticleId></ArticleIdList></Reference><Reference><Citation>Anggakusuma Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 2014;63(7):1137&#x2013;49. 10.1136/gutjnl-2012-304299 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-304299</ArticleId><ArticleId IdType="pubmed">23903236</ArticleId></ArticleIdList></Reference><Reference><Citation>Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol. 2010;80(12):1895&#x2013;903. 10.1016/j.bcp.2010.07.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2010.07.014</ArticleId><ArticleId IdType="pubmed">20643109</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Li H, Hou X, Li D, He S, Wan C, et al. Punicalagin Induces Nrf2/HO-1 Expression via Upregulation of PI3K/AKT Pathway and Inhibits LPS-Induced Oxidative Stress in RAW264.7 Macrophages. Mediators Inflamm. 2015;2015:380218 10.1155/2015/380218</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/380218</ArticleId><ArticleId IdType="pmc">PMC4417599</ArticleId><ArticleId IdType="pubmed">25969626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin F, Liu J, Zheng X, Guo L, Xiao H. Geniposide induces the expression of heme oxygenase-1 via PI3K/Nrf2-signaling to enhance the antioxidant capacity in primary hippocampal neurons. Biol Pharm Bull. 2010;33(11):1841&#x2013;6. .</Citation><ArticleIdList><ArticleId IdType="pubmed">21048309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci U S A. 1994;91(8):3147&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43532</ArticleId><ArticleId IdType="pubmed">8159717</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A. 1997;94(19):10367&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23369</ArticleId><ArticleId IdType="pubmed">9294217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung FL, Conaway CC, Rao CV, Reddy BS. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis. 2000;21(12):2287&#x2013;91. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11133820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A. 2002;99(11):7610&#x2013;5. 10.1073/pnas.112203099</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.112203099</ArticleId><ArticleId IdType="pmc">PMC124299</ArticleId><ArticleId IdType="pubmed">12032331</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, et al. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res. 2011;28(12):3171&#x2013;9. 10.1007/s11095-011-0500-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-011-0500-z</ArticleId><ArticleId IdType="pmc">PMC3253624</ArticleId><ArticleId IdType="pubmed">21681606</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwell LL, Hsu A, Wong CP, Stevens JF, Bella D, Yu TW, et al. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract. Molecular nutrition &amp; food research. 2015;59(3):424&#x2013;33. 10.1002/mnfr.201400674</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201400674</ArticleId><ArticleId IdType="pmc">PMC4394840</ArticleId><ArticleId IdType="pubmed">25522265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R, Hebbar V, Kim BR, Chen C, Winnik B, Buckley B, et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther. 2004;310(1):263&#x2013;71. 10.1124/jpet.103.064261 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.103.064261</ArticleId><ArticleId IdType="pubmed">14988420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>